• Live Feeds
    • Press Releases
    • Insider Trading
    • FDA Approvals
    • Analyst Ratings
    • Insider Trading
    • SEC filings
    • Market insights
  • Analyst Ratings
  • Alerts
  • Subscriptions
  • Settings
  • RSS Feeds
Quantisnow Logo
  • Live Feeds
    • Press Releases
    • Insider Trading
    • FDA Approvals
    • Analyst Ratings
    • Insider Trading
    • SEC filings
    • Market insights
  • Analyst Ratings
  • Alerts
  • Subscriptions
  • Settings
  • RSS Feeds
PublishDashboard
    Quantisnow Logo

    © 2025 quantisnow.com
    Democratizing insights since 2022

    Services
    Live news feedsRSS FeedsAlertsPublish with Us
    Company
    AboutQuantisnow PlusContactJobsAI employees
    Legal
    Terms of usePrivacy policyCookie policy

    Jacobs Jeffrey Scott converted options into 713 shares, increasing direct ownership by 4% to 20,004 units (SEC Form 4)

    2/7/24 7:19:45 PM ET
    $CDAY
    EDP Services
    Technology
    Get the next $CDAY alert in real time by email
    SEC FORM 4 SEC Form 4
    FORM 4 UNITED STATES SECURITIES AND EXCHANGE COMMISSION
    Washington, D.C. 20549

    STATEMENT OF CHANGES IN BENEFICIAL OWNERSHIP

    Filed pursuant to Section 16(a) of the Securities Exchange Act of 1934
    or Section 30(h) of the Investment Company Act of 1940
    OMB APPROVAL
    OMB Number: 3235-0287
    Estimated average burden
    hours per response: 0.5
      
    Check this box if no longer subject to Section 16. Form 4 or Form 5 obligations may continue. See Instruction 1(b).
      
    Check this box to indicate that a transaction was made pursuant to a contract, instruction or written plan for the purchase or sale of equity securities of the issuer that is intended to satisfy the affirmative defense conditions of Rule 10b5-1(c). See Instruction 10.
    1. Name and Address of Reporting Person*
    Jacobs Jeffrey Scott

    (Last) (First) (Middle)
    C/O DAYFORCE, INC.
    3311 EAST OLD SHAKOPEE ROAD

    (Street)
    MINNEAPOLIS MN 55425

    (City) (State) (Zip)
    2. Issuer Name and Ticker or Trading Symbol
    Dayforce, Inc. [ DAY ]
    5. Relationship of Reporting Person(s) to Issuer
    (Check all applicable)
    Director 10% Owner
    X Officer (give title below) Other (specify below)
    Head of Acct & Fin Reporting
    3. Date of Earliest Transaction (Month/Day/Year)
    02/05/2024
    4. If Amendment, Date of Original Filed (Month/Day/Year)
    6. Individual or Joint/Group Filing (Check Applicable Line)
    X Form filed by One Reporting Person
    Form filed by More than One Reporting Person
    Table I - Non-Derivative Securities Acquired, Disposed of, or Beneficially Owned
    1. Title of Security (Instr. 3) 2. Transaction Date (Month/Day/Year) 2A. Deemed Execution Date, if any (Month/Day/Year) 3. Transaction Code (Instr. 8) 4. Securities Acquired (A) or Disposed Of (D) (Instr. 3, 4 and 5) 5. Amount of Securities Beneficially Owned Following Reported Transaction(s) (Instr. 3 and 4) 6. Ownership Form: Direct (D) or Indirect (I) (Instr. 4) 7. Nature of Indirect Beneficial Ownership (Instr. 4)
    Code V Amount (A) or (D) Price
    Common Stock 02/05/2024 M 713 A (1) 20,004(2) D
    Table II - Derivative Securities Acquired, Disposed of, or Beneficially Owned
    (e.g., puts, calls, warrants, options, convertible securities)
    1. Title of Derivative Security (Instr. 3) 2. Conversion or Exercise Price of Derivative Security 3. Transaction Date (Month/Day/Year) 3A. Deemed Execution Date, if any (Month/Day/Year) 4. Transaction Code (Instr. 8) 5. Number of Derivative Securities Acquired (A) or Disposed of (D) (Instr. 3, 4 and 5) 6. Date Exercisable and Expiration Date (Month/Day/Year) 7. Title and Amount of Securities Underlying Derivative Security (Instr. 3 and 4) 8. Price of Derivative Security (Instr. 5) 9. Number of derivative Securities Beneficially Owned Following Reported Transaction(s) (Instr. 4) 10. Ownership Form: Direct (D) or Indirect (I) (Instr. 4) 11. Nature of Indirect Beneficial Ownership (Instr. 4)
    Code V (A) (D) Date Exercisable Expiration Date Title Amount or Number of Shares
    Performance Units (1) 02/05/2024 M 713 (1) 02/28/2033 Common Stock 713 $0 0 D
    Option (right to buy) $17.58 (3) 12/08/2025 Common Stock 500 500 D
    Option (right to buy) $16.82 (3) 12/31/2026 Common Stock 1,125 1,125 D
    Option (right to buy) $19.04 (3) 12/20/2027 Common Stock 5,000 5,000 D
    Option (right to buy) $22 (3) 04/25/2028 Common Stock 32,610 32,610 D
    Option (right to buy) $44.91 (3) 02/08/2029 Common Stock 712 712 D
    Option (right to buy) $49.93 (3) 03/20/2029 Common Stock 8,396 8,396 D
    Option (right to buy) $65.26 (4) 05/08/2030 Common Stock 14,299 14,299 D
    Performance Units (5) (5) 03/08/2031 Common Stock 824 824 D
    Performance Units (6) (6) 02/24/2032 Common Stock 2,352 2,352 D
    Explanation of Responses:
    1. On February 28, 2023, the Reporting Person was granted performance stock units ("PSUs") subject to the Company's 2023 Management Incentive Plan, the vesting of which was subject to both performance-based and service-based criteria. The number of shares reported represents the number of PSUs that were earned as a result of the achievement of such performance criteria. Such earned PSUs will vest as to service on February 28, 2024, subject to the Reporting Person remaining in continuous Service (as defined in the Company's 2018 Equity Incentive Plan) of the Company as of such date.
    2. Includes (i) 7,416 shares of common stock of the Company ("Common Stock"), which includes 126 shares acquired under the Dayforce, Inc. Global Employee Stock Purchase Plan ("GESPP") on June 30, 2023 and 136 shares acquired under the GESPP on September 30, 2023, (ii) shares of Common Stock that are issuable pursuant to restricted stock units ("RSUs"), granted on March 8, 2021, of which 824 shares vest on March 8, 2024; (iii) shares of Common Stock issuable pursuant to RSUs, granted on February 24, 2022, of which 1,412 shares vest on each of February 24, 2024 and February 24, 2025; (iv) shares of Common Stock issuable pursuant to RSUs, granted on February 28, 2023, of which 2,742 shares vest on each of February 28, 2024 and February 28, 2025, and 2,743 shares vest on February 28, 2026; and (v) shares of Common Stock issuable pursuant to PSUs, granted on February 28, 2023, of which 713 shares vest on February 28, 2024.
    3. Fully vested and exercisable.
    4. Consists of 10,724 vested and exercisable options as of May 8, 2023, and 3,575 options that vest and become exercisable on May 8, 2024.
    5. Given the Company's performance in 2021 and pursuant to the terms of the PSU award agreement, each PSU granted on March 8, 2021 will convert into 1 share of Common Stock upon vesting. The vesting of 824 PSUs occurs on March 8, 2024.
    6. Given the Company's performance in 2022 and pursuant to the terms of the PSU award agreement, each PSU granted on February 24, 2022 will convert into 1 share of Common Stock upon vesting. The vesting of 1,176 PSUs occurs on each of February 24, 2024 and February 24, 2025.
    Remarks:
    Exhibit List 24. Power of Attorney
    /s/ William E. McDonald, attorney-in-fact 02/07/2024
    ** Signature of Reporting Person Date
    Reminder: Report on a separate line for each class of securities beneficially owned directly or indirectly.
    * If the form is filed by more than one reporting person, see Instruction 4 (b)(v).
    ** Intentional misstatements or omissions of facts constitute Federal Criminal Violations See 18 U.S.C. 1001 and 15 U.S.C. 78ff(a).
    Note: File three copies of this Form, one of which must be manually signed. If space is insufficient, see Instruction 6 for procedure.
    Persons who respond to the collection of information contained in this form are not required to respond unless the form displays a currently valid OMB Number.
    Get the next $CDAY alert in real time by email

    Chat with this insight

    Save time and jump to the most important pieces.

    Recent Analyst Ratings for
    $CDAY

    DatePrice TargetRatingAnalyst
    1/10/2024$75.00Buy
    Stifel
    11/7/2023$87.00Buy
    UBS
    10/23/2023$74.00Neutral
    Goldman
    10/5/2023$82.00Hold → Buy
    Needham
    7/13/2023$69.00 → $71.00Outperform → Market Perform
    TD Cowen
    1/9/2023$68.00Market Perform
    MoffettNathanson
    10/31/2022$54.00 → $64.00Underweight → Equal Weight
    Barclays
    9/1/2022$73.00Buy
    Citigroup
    More analyst ratings

    $CDAY
    SEC Filings

    See more
    • Ceridian HCM Holding Inc. filed SEC Form 8-K: Results of Operations and Financial Condition, Financial Statements and Exhibits

      8-K - Dayforce, Inc. (0001725057) (Filer)

      2/7/24 7:17:41 AM ET
      $CDAY
      EDP Services
      Technology
    • Ceridian HCM Holding Inc. filed SEC Form 8-K: Amendments to Articles of Incorporation or Bylaws; Change in Fiscal Year, Regulation FD Disclosure, Financial Statements and Exhibits

      8-K - Dayforce, Inc. (0001725057) (Filer)

      2/1/24 7:48:19 AM ET
      $CDAY
      EDP Services
      Technology
    • Ceridian HCM Holding Inc. filed SEC Form 8-K: Leadership Update, Regulation FD Disclosure, Financial Statements and Exhibits

      8-K - Ceridian HCM Holding Inc. (0001725057) (Filer)

      12/4/23 4:24:52 PM ET
      $CDAY
      EDP Services
      Technology